ArticleMaterials today. Bio2026

Corrigendum to 'Engineered nano-bacteria hybrids for precision cancer immunotherapy' [Mater. Today Bio

Liang Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.